A qualitative distinction between the beta-receptor-blocking and local anesthetic actions of antiarrhythmic agents.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002118:Calcium / Q000378:metabolism; D004285:Dogs; D006321:Heart / Q000187:drug effects*; D008012:Lidocaine / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D011433:Propranolol / Q000494:pharmacology*; D011802:Quinidine / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology*; D013748:Tetracaine / Q000494:pharmacology*
D013565:Sympatholytics; D013748:Tetracaine; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D002118:Calcium